History of Success Trading FDA Catalyst Events: $CAMH, $AEN, $NVLT, $GTHP, $CTIC (IBB, rated BUY)

Posted on June 01, 2010 at 18:52 PM EDT

Written by Mark Messier (BioRunUp.com) . I would like to point out some of the benefits that I personally have experienced by taking advantage of my membership to Mike Havrilla's website at MikeHavRX.com over the past year. Lets take a look at some of my picks using Mike's Biotech Regulatory Catalyst Index and how they have performed. If you question when I picked them and the price on the day of my pick, click on the link that takes you to the MyStockBuddy.com forum where the threads were started. CAMH - Cambridge Heart Price at "Discovery": $.13 Date of "Discovery": 2/22/10 Peak Price: $.75 Date of Peak Price: 4/15/10 Potential Profit: 477% AEN - Adeona Pharmaceuticals Price at "Discovery": $.70 Date of "Discovery": 9/7/09 Peak Price: $2.70 Date of Peak Price: 3/30/10 Potential Profit: 286% NVLT - Novelos Therapeutics Price at "Discovery": $.85 Date of "Discovery": 7/2/09 Peak Price: $3.05 Date of Peak Price: 01/04/10 Potential Profit: 259% GTHP - Guided Therapeutics Price at "Discovery": $.36 Date of "Discovery": 10/05/09 Peak Price: $1.70 Date of Peak Price: 11/20/09 Potential Profit: 372% Conclusion I believe that one of the best ways to make big gains in trading biotech is to get in early. Many times, by the time you hear about some of these plays from websites, forums, or email subscriptions, the biggest pop in price has already occurred. This is exactly why I have been following Mike Havrilla's calendar updates for almost a year now. He provided the information for BioMedReports FDA calendar up until a few months ago when he broke away from their advancing pump and dump schemes. Mike is now running his own calendar and biotech investor website which is updated daily with 10-20 new calendar items, as well as integration with Google Calendar and BioCatalyst Index Tracking. I encourage you to check out his site and consider signing up. I am confident that by combining the methods on BioRunUp.com with the unbiased research on MikeHavRX.com you will become a more profitable trader. www.mikehavRx.com is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 568 entries and 364 companies (including approximately 200 stocks trading under $5 per share and 25 private companies). Promo codes (50% discount) are available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services. Disclosure: No positions